Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab
Go back to Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1098.57 -13.43 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1112.00 | 52 Week High | $88.16 | |||
| Open | $1120.49 | 52 Week Low | $67.88 | |||
| Day High | $1122.33 | P/E | 254.30 | |||
| Day Low | $1088.66 | EPS | $4.32 | |||
| Volume | 4,470,563 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.21 -0.71 (2.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.92 | 52 Week High | $37.39 | |||
| Open | $25.58 | 52 Week Low | $28.25 | |||
| Day High | $25.36 | P/E | 15.28 | |||
| Day Low | $24.94 | EPS | $1.65 | |||
| Volume | 119,614,341 | |||||
